Quality control assessment of human immunodeficiency virus type 2 (HIV-2) viral load quantification assays:: Results from an international collaboration on HIV-2 infection in 2006

被引：33

作者：

Damond, Florence ^{[1
]}

Benard, Antoine ^{[2
]}

Ruelle, Jean ^{[3
]}

Alabi, Abraham ^{[4
]}

Kupfer, Bernd ^{[5
]}

Gomes, Perpetua ^{[7
]}

Rodes, Berta ^{[6
]}

Albert, Jan ^{[8
,9
]}

Boeni, Juerg ^{[10
]}

Garson, Jeremy ^{[11
]}

Ferns, Bridget ^{[11
]}

Matheron, Sophie ^{[12
]}

Chene, Genevieve ^{[2
]}

Vezinet, Francoise Brun ^{[1
]}

机构：

[1] Hop Bichat Claude Bernard, Virol Lab, APHP, F-75018 Paris, France

[2] Univ Bordeaux 2, INSERM, U897, ISPED, F-33076 Bordeaux, France

[3] Catholic Univ Louvain, AIDS Reference Lab, B-1348 Louvain, Belgium

[4] MRC Labs, Banjul, Gambia

[5] Inst Virol, Bonn, Germany

[6] Hosp Carlos III, Dept Infect Dis, Madrid, Spain

[7] CHLO Hosp Egas Moniz, Mol Biol Lab, Lisbon, Portugal

[8] Swedish Inst Infect Dis Control, Dept Virol, Solna, Sweden

[9] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden

[10] Swiss HIV Cohort Study, Zurich, Switzerland

[11] UCL Royal Free & Univ Coll Med Sch, Ctr Virol, London WC1E 6BT, England

[12] Hop Bichat Claude Bernard, Serv Malad Infect & Trop, APHP, F-75877 Paris 18, France

来源：

JOURNAL OF CLINICAL MICROBIOLOGY | 2008年 / 46卷 / 06期

基金：

英国医学研究理事会;

关键词：

D O I：

10.1128/JCM.00126-08

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Human immunodeficiency virus type 2 (HIV-2) RNA quantification assays used in nine laboratories of the ACHIEV2E (A Collaboration on HIV-2 Infection) study group were evaluated. In a blinded experimental design, laboratories quantified three series of aliquots of an HIV-2 subtype A strain, each at a different theoretical viral load. Quantification varied between laboratories, and international standardization of quantification assays is strongly needed.

引用

页码：2088 / 2091

页数：4

共 50 条

[21] Human immunodeficiency virus (HIV) type-1, HIV-2 and simian immunodeficiency virus Nef proteins
Laguette, Nadine
Bregnard, Christelle
Benichou, Serge
Basmaciogullari, Stephane
MOLECULAR ASPECTS OF MEDICINE, 2010, 31 (05) : 418 - 433
[22] Direct evidence of lower viral replication rates in vivo in human immunodeficiency virus type 2 (HIV-2) infection than in HIV-1 infection
MacNeil, Adam
Sarr, Abdoulaye Dieng
Sankale, Jean-Louis
Meloni, Seema Thakore
Mboup, Souleymane
Kanki, Phyllis
JOURNAL OF VIROLOGY, 2007, 81 (10) : 5325 - 5330
[23] HIV-2 infection and human lymphotropic type 1 and type 2 virus in Spain
Toro, Carlos
Soriano, Vicente
MEDICINA CLINICA, 2007, 129 (01): : 14 - 16
[24] Human immunodeficiency virus type 2 (HIV-2) seroprevalence and characterization of a distinct HIV-2 genetic subtype from the natural range of simian immunodeficiency virus-infected sooty mangabeys
Chen, ZW
Luckay, A
Sodora, DL
Telfer, P
Reed, P
Gettie, A
Kanu, JM
Zhang, LQ
Sadek, RF
Yee, J
Ho, DD
Marx, PA
JOURNAL OF VIROLOGY, 1997, 71 (05) : 3953 - 3960
[25] Dendritic cells are less susceptible to human immunodeficiency virus type 2 (HIV-2) infection than to HIV-1 infection
Duvall, Melody G.
Lore, Karin
Blaak, Hetty
Ambrozak, David A.
Adams, William C.
Santos, Kathlyn
Geldmacher, Christof
Mascola, John R.
McMichael, Andrew J.
Jaye, Assan
Whittle, Hilton C.
Rowland-Jones, Sarah L.
Koup, Richard A.
JOURNAL OF VIROLOGY, 2007, 81 (24) : 13486 - 13498
[26] First-line Raltegravir/Emtricitabine/Tenofovir Combination in Human Immunodeficiency Virus Type 2 (HIV-2) Infection: A Phase 2, Noncomparative Trial (ANRS 159 HIV-2)
Matheron, Sophie
Descamps, Diane
Gallien, Sebastien
Besseghir, Amel
Sellier, Pierre
Blum, Laurent
Mortier, Emmanuel
Charpentier, Charlotte
Tubiana, Roland
Damond, Florence
Peytavin, Gilles
Ponscarme, Diane
Collin, Fideline
Brun-Vezinet, Francoise
Chene, Genevieve
CLINICAL INFECTIOUS DISEASES, 2018, 67 (08) : 1161 - 1167
[27] Plasma and tissue HIV-1 and HIV-2 viral load in HIV-2 and dual HIV-1/HIV-2 infected individuals: Implications for starting HAART
Schutten, M
van der Ende, ME
Tenner-Racz, K
Racz, P
Niesters, HGM
Osterhaus, ADME
AIDS, 2000, 14 : S3 - S3
[28] BIOLOGIC HETEROGENEITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 (HIV-2) STRAINS
CASTRO, BA
BARNETT, SW
EVANS, LA
MOREAU, J
ODEHOURI, K
LEVY, JA
VIROLOGY, 1990, 178 (02) : 527 - 534
[29] Computational studies of inhibitor binding to human immunodeficiency virus, Type 2 (HIV-2) protease
Summay, Russell
Waingeh, Victor
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 249
[30] Variability of human immunodeficiency virus type 2 (HIV-2) infecting patients living in France
Damond, F
Apetrei, C
Robertson, DL
Souquière, S
Leprêtre, A
Matheron, S
Plantier, JC
Brun-Vézinet, F
Simon, F
VIROLOGY, 2001, 280 (01) : 19 - 30

← 1 2 3 4 5 →